SCP-6062
Unknown
~
medium confidence
SCP-6062
Expected annual
$2.9M
One-time setup
$6.8M
Annual recurring
$2.9M
Personnel
10
Initial capital costs are approximately $6,762,500 driven primarily by containment construction and an emergency/reserve fund; annual recurring costs are approximately $2,874,500/yr driven by staffing, ongoing biosurveillance/research, and rapid-response readiness.
One-Time Capital Costs
Total: $6.8M
Annual Recurring Costs
Total: $2.9M/yr
Cost Scenarios
📊
Baseline
(baseline)
$2.9M/yr
Normal operational year with no major incidents; routine containment, research and monitoring activities proceed as planned.
routine operations
scheduled maintenance
normal research throughput
🚨
Minor Incident
$3.1M/yr
Localized exposure or small containment lapse requiring medical treatment, decontamination, overtime and limited external response.
localized exposure
minor containment breach
limited medical response
🚨
Major Breach
$7.9M/yr
Significant containment failure or exposure involving high-consequence pathogens (e.g., smallpox/plague) requiring large-scale response, external public-health coordination and use of contingency funds.
major containment breach
cross-facility exposure
regional public-health response
Personnel
10 total
| Role | Count | Notes |
|---|---|---|
| Containment Technician | 3 | [#7] Full-time containment technicians responsible for cleaning, monitoring and hands-on containment. |
| Security Officer / MTF Agent | 4 | [#7] Dedicated on-site security staff for 24/7 security and access control. |
| Biosafety Officer | 1 | [#7] Oversees biosafety compliance, monitoring and incident response planning. |
| Veterinary / Animal Tech | 1 | [#7] On-site veterinary or animal technician for health monitoring and husbandry. |
| Facility Manager | 1 | [#7] Manages facility operations, maintenance contracts and logistics. |
Confidence Notes
Detailed analyst notes allow a bounded estimate for equipment, staffing and recurring research; uncertainty remains around breach probabilities, scale of external public-health responses, and future discovery rate of novel pathogens, so confidence is medium.